UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Supportive management

Memo - Magazine of European medical oncology, 2023-12, Vol.16 (4), p.220-221

Minichsdorfer, PhD, Christoph

2023

Link zum Volltext

Verfügbarkeit prüfen

Serum parameters as prognostic biomarkers in a real world cancer patient population treated with anti PD-1/PD-L1 therapy

Annals of medicine (Helsinki), 2022-12, Vol.54 (1), p.1339-1349

2022

Link zum Volltext

Verfügbarkeit prüfen

Expectations and perception of cancer treatment goals in previously untreated patients. The EXPECT trial

Supportive care in cancer, 2021-07, Vol.29 (7), p.3585-3592

2021

Link zum Volltext

Verfügbarkeit prüfen

Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non―Small Cell Lung Cancers

Clinical cancer research, 2012-03, Vol.18 (6), p.1619-1629

2012

Link zum Volltext

Verfügbarkeit prüfen

PD-L1 Expression on Tumor Cells Is Associated With a Poor Outcome in a Cohort of Caucasian Nasopharyngeal Carcinoma Patients

Frontiers in oncology, 2019-11, Vol.9, p.1334-1334

2019

Link zum Volltext

Verfügbarkeit prüfen

Autocrine secretion of 15d‐PGJ2 mediates simvastatin‐induced apoptotic burst in human metastatic melanoma cells

British journal of pharmacology, 2014-12, Vol.171 (24), p.5708-5727

2014

Link zum Volltext

Verfügbarkeit prüfen

DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma

Journal for immunotherapy of cancer, 2022-03, Vol.10 (3), p.e003420

2022

Link zum Volltext

Verfügbarkeit prüfen

Systemic therapy for metastatic salivary gland tumors—challenges and novel concepts

Memo - Magazine of European medical oncology, 2020-12, Vol.13 (4), p.400-404

Minichsdorfer, Christoph

2020

Link zum Volltext

Verfügbarkeit prüfen

Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial

Infectious agents and cancer, 2023-02, Vol.18 (1), p.9-9, Article 9

2023

Link zum Volltext

Verfügbarkeit prüfen

SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment

Translational oncology, 2019-01, Vol.12 (1), p.15-23

2019

Link zum Volltext

Verfügbarkeit prüfen

HPV-associated cancers

Memo - Magazine of European medical oncology, 2019-12, Vol.12 (4), p.352-356

Minichsdorfer, Christoph

2019

Link zum Volltext

Verfügbarkeit prüfen

Different Toxicity Profiles Predict Third Line Treatment Efficacy in Metastatic Colorectal Cancer Patients

Journal of clinical medicine, 2020-06, Vol.9 (6), p.1772

2020

Link zum Volltext

Verfügbarkeit prüfen

Results from the FeDeriCa trial: are we reducing the burden of breast cancer treatment?

The lancet oncology, 2021-01, Vol.22 (1), p.5-6

2021

Link zum Volltext

Verfügbarkeit prüfen

Co-treatment of statins and erlotinib to induce growth arrest and apoptosis in primary TKI-resistant non-small cell lung cancer (NSCLC)-cell lines

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e22181-e22181

2015

Link zum Volltext

Verfügbarkeit prüfen

Optimal use of granulocyte colony-stimulating factor prophylaxis to improve survival in cancer patients receiving treatment: An expert view

Wiener Klinische Wochenschrift, 2024-06, Vol.136 (11-12), p.362-368

2024

Link zum Volltext

Verfügbarkeit prüfen

Characterization of oncologic patient visits at the emergency department (ED) at an Austrian tertiary care center

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.6609-6609

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of COVID‐19 lockdown on routine oncology versus emergency care at a high volume cancer centre

European journal of clinical investigation, 2021-08, Vol.51 (8), p.e13623-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 336: IL-6 primes melanoma cells from early stages to statin induced apoptosis

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.336-336

2014

Link zum Volltext

Verfügbarkeit prüfen

Complication Rates of Peripherally Inserted Central Catheters in Oncologic Versus Non-Oncologic Patients

Seminars in oncology nursing, 2024-06, p.151681, Article 151681

2024

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab plus docetaxel for the treatment of recurrent/metastatic head and neck cancer: A prospective phase I/II study

Oral oncology, 2022-01, Vol.124, p.105634, Article 105634

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-15-01: Effect of concomitant statin treatment in postmenopausal patients with hormone-receptor positive early-stage breast cancer receiving adjuvant denosumab or placebo: A post-hoc analysis of ABCSG-18

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P1-P1-15-01

2022

Link zum Volltext

Verfügbarkeit prüfen

Adolescents and Young Adults (AYAs) With Initially Localized and Metastatic Bone Sarcomas: A Retrospective Single Center Analysis of Side Effect Management

In vivo (Athens), 2021-01, Vol.35 (1), p.385-391

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5233: Towards patient-centric drug discovery: Analyzing drug action in malignant pleural effusions and ascites using high content imaging and deep learning

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.5233-5233

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(48)

Sprache

Englisch
(48)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Supportive management

Serum parameters as prognostic biomarkers in a real world cancer patient population treated with anti PD-1/PD-L1 therapy

Expectations and perception of cancer treatment goals in previously untreated patients. The EXPECT trial

Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non―Small Cell Lung Cancers

PD-L1 Expression on Tumor Cells Is Associated With a Poor Outcome in a Cohort of Caucasian Nasopharyngeal Carcinoma Patients

Autocrine secretion of 15d‐PGJ2 mediates simvastatin‐induced apoptotic burst in human metastatic melanoma cells

DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma

Systemic therapy for metastatic salivary gland tumors—challenges and novel concepts

Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial

SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment

HPV-associated cancers

Different Toxicity Profiles Predict Third Line Treatment Efficacy in Metastatic Colorectal Cancer Patients

Results from the FeDeriCa trial: are we reducing the burden of breast cancer treatment?

Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial

Co-treatment of statins and erlotinib to induce growth arrest and apoptosis in primary TKI-resistant non-small cell lung cancer (NSCLC)-cell lines

Optimal use of granulocyte colony-stimulating factor prophylaxis to improve survival in cancer patients receiving treatment: An expert view

Characterization of oncologic patient visits at the emergency department (ED) at an Austrian tertiary care center

Impact of COVID‐19 lockdown on routine oncology versus emergency care at a high volume cancer centre

Abstract 336: IL-6 primes melanoma cells from early stages to statin induced apoptosis

Complication Rates of Peripherally Inserted Central Catheters in Oncologic Versus Non-Oncologic Patients

Pembrolizumab plus docetaxel for the treatment of recurrent/metastatic head and neck cancer: A prospective phase I/II study

Abstract P1-15-01: Effect of concomitant statin treatment in postmenopausal patients with hormone-receptor positive early-stage breast cancer receiving adjuvant denosumab or placebo: A post-hoc analysis of ABCSG-18

FINAL outcome ANALYSIS FROM THE PHASE II TUXEDO-1 TRIAL OF TRASTUZUMAB-DERUXTECAN IN HER2-positive breast cancer PATIENTS WITH active brain metastases

Adolescents and Young Adults (AYAs) With Initially Localized and Metastatic Bone Sarcomas: A Retrospective Single Center Analysis of Side Effect Management

Abstract 5233: Towards patient-centric drug discovery: Analyzing drug action in malignant pleural effusions and ascites using high content imaging and deep learning

Suchergebnisse filtern